Unmet clinical need in autoimmune liver diseases
Open Access
- 15 September 2014
- journal article
- review article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 62 (1), 208-218
- https://doi.org/10.1016/j.jhep.2014.09.010
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Treatment of autoimmune liver disease: current and future therapeutic optionsTherapeutic Advances in Chronic Disease, 2013
- Cancer surveillance in patients with primary sclerosing cholangitisHepatology, 2011
- Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosisNature Genetics, 2011
- B cell depletion therapy exacerbates murine primary biliary cirrhosisHepatology, 2010
- Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosisJournal of Hepatology, 2010
- Primary Biliary Cirrhosis Associated withHLA, IL12A,andIL12RB2VariantsNew England Journal of Medicine, 2009
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitisHepatology, 2009
- Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assayHepatology, 2008
- Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-AnalysisGastroenterology, 2008
- Optimising corticosteroid treatment for autoimmune pancreatitisGut, 2007